Investor
LSX World Congress USA
An investment and partnering conference connecting life science executive leadership with international healthcare investors.
- When
- September, Early September
- Where
- Boston, USA
- Format
- In person
- Organiser
- LSX
- Region
- North America
- Scale
- About 400 attendees
- Founded
- 2017
The briefing
LSX World Congress USA is an annual executive-level partnering and investment conference run by LSX. The event is designed to connect biotechnology, medtech, and digital health executives with global investors and pharma business development teams. Its primary focus is on facilitating structured, one-to-one partnering meetings to drive deal-making and fundraising. For early-stage and growth-stage healthtech operators, this congress is a highly efficient platform for initiating fundraising rounds and strategic alliances.
What to expect
- Early-stage venture capital fundraising trends
- Strategic licensing and pharmaceutical partnering deals
- Growth-stage capital allocation strategies
- Biotech and medtech public market readiness
Who is in the room
Biotech and medtech executive officers, venture capital partners, institutional investors, and pharmaceutical corporate development teams attend.
Background
Expanded from the successful London-based LSX World Congress to address the North American life sciences market. It has become a key Boston-based event for executive networking and investment matchmaking.
Related events
Running this event, or spotted something out of date?